ArticleJournal of neuro-oncology2025
Evaluating safety and feasibility of same-day discharge after laser interstitial thermal therapy: a pilot study with a matched control group.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07104890 (Evaluation of Enhanced Recovery After Surgery), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Enhanced Recovery After Surgery (ERAS) Protocol on Postoperative Recovery in Elective Cesarean Sections
Who cites it
1 citing paper in PubMed.
- Outpatient Surgery in Neuro-Oncology-Advancing Patient Access and Care.Current oncology (Toronto, Ont.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLaser interstitial thermal therapy (LITT) is a minimally invasive treatment for intracranial tumors. Enhanced recovery after surgery (ERAS) protocols aim to optimize patient outcomes, and same-day discharge (SDD) is an emerging strategy to improve efficiency while maintaining safety. This pilot study evaluates the feasibility and safety of SDD following LITT.
methodsA retrospective review was conducted of patients who underwent LITT with planned SDD between May 2023 and June 2024 at our institution. Patients successfully discharged on the same day (study group) were match-paired 1:3 based on age, gender, and pathology, with patients discharged on post-ablation day 1 (control group) between January 2014 and April 2023. Demographic, perioperative, and treatment outcomes were compared.
resultsSDD was achieved in 10 patients (mean age 56.80 ± 11.43 years, 70% males), compared to 30 controls (mean age 58.87 ± 12.23, 70% males). SDD patients had a significantly shorter observation period (p < 0.001). No differences were observed in postoperative edema (p = 0.640), midline shift (p = 0.195), Karnofsky Performance Status (KPS) at follow-up (p = 0.999), 30-day postoperative complications (p = 0.620), 30-day neurosurgical complications (p = 0.999), 30-day readmission (p = 0.584), 30-day neurosurgical readmission (p = 0.999), or 90-day mortality (p = 0.999) between groups.
conclusionOur findings suggest that SDD following LITT is safe and feasible for appropriately selected patients. Rigorous patient selection and optimized perioperative protocols facilitate expedited recovery without compromising safety.
Indexed as
Identifiers
40355785What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.